The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy

NCT ID: NCT01617837

Last Updated: 2013-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate if P6 acupressure may reduce postoperative nausea and vomiting in neurosurgical patients undergoing craniotomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary aim of this study is to investigate if P6 acupressure can reduce postoperative nausea after craniotomy. Calculation of sample size was based on the assumptions to detect at difference of 20% between the patients (38% in the control group vs 18% in the acupressure group) for the primary endpoint; incidence of nausea during the first 24 hours postoperatively, with a significance level 5% and a power of 80%, guided by an earlier study with a similar population (Wang et. al. 2010) and the assumption that 38% of our patients suffer from nausea. These assumptions suggested a sample size of 78 patients (39 patients / group) that resulted in a sample size of 80 patients for covering attrition. Secondary aims are to investigate if the frequency of vomiting and the need for antiemetic can be reduced with P6 acupressure.

Patients are randomly assigned into one of two treatment groups using a computer-generated random number table, either P6 acupressure group or placebo group. Randomization and sealing of the study envelopes, containing all study material and following the patients all through the study, are performed by persons from the research department, who is not involved in the data collection. Information and study protocol are included in the envelope. The randomization is taking place preoperatively. Sea-Band®, a single-sized elastic acupressure band with a plastic button placed at P6 to apply pressure is used. One group will receive an active acupressure band and the other an identical placebo band without any button. Before entering the operation ward both wrists are marked at the place for P6, performed by staff at the neurosurgical ward. The active acupressure bands and the placebo bands are administered at the end of surgery. They are placed unilaterally at the wrist by the nurse anesthetist who performs the patient's anesthesia. The manufacturer's guidelines of where and how to place the band are included in the envelope with study material. Both the P6 acupressure bands and the placebo bands are covered with a bandage to ensure blinding to the patients and the nursing staff involved in the postoperative care. Both the P6 acupressure bands and the placebo bands will be removed 48 hours postoperatively. If the bands cause discomfort, they can be removed for 30 minutes every two hours, performed by staff not involved in the postoperative care, with instructions to cover the wrist with a cotton roll while airing the arm, this for ensuring further blinding if the acupressure has caused any betrayal marks.

At the end of the surgery all patients receive ondansetron 4mg IV. Droperidol IV is administered as additional perioperative antiemetic if considered necessary. Postoperatively rescue antiemetics are administrated according to current routines. The administered drugs are 0,625-1,25mg droperidol and 1-4mg ondansetron, either alone or in combination. Postoperative opioid administration (morphine and ketobemidone) are also recorded during the time of the study

Before operation all patients are filling in a health declare formula as a routine in the anesthetic preparation. This formula includes the four risk factors for PONV, according to Apfel and colleagues (Apfel et al. 1999). To clarify earlier PONV there is a specific question about this issue on the formula of written consent.

During 48 hours postoperatively the patients are evaluating their nausea which is registered on the same formula as the frequencies of vomiting. The first evaluation is taking part when arriving to the postoperative care unit and then every hour for the first six hours, every third hour until hour 24 and thereafter every sixth hour from hour 25-48. A Numerical Rating Scale (NRS) from 0-10 is used, where 0 mean no nausea at all and 10 the worst nausea possible. The patients are asked about whether they have experienced any nausea within the previous period of time. Assessment of nausea and registration of the vomiting frequency are performed by staff unaware of the patient's group in the postoperative care unit/neurosurgical ward and by the patients themselves when possible.

After discharge the data from the NRS formula are collected. The patients' journals are screened for administrated antiemetic and opioids, for potential risk factors for PONV and for other demographics relevant to the study outcome. All data are saved anonymously in the software Statistical Package for Social Sciences (SPSS).

Overall PONV is defined as at least one episode of nausea or vomiting during the observation time of 48 h. Rescue therapy is defined as at least one dosage of either droperidol or ondansetron during the observation time of 48 h. Early PONV is defined as PONV occurring up to 6 hours postoperatively and late PONV 7-48 hours postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Nausea and Vomiting Acupressure Craniotomy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Postoperative nausea and vomiting P6 acupressure Craniotomy.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

P6 acupressure group

In the end of the operation Sea-Band®, a single-sized elastic acupressure band with a plastic button, was placed unilaterally at the place of P6 (the P6 "Neiguan" acupoint, located about 3 cm proximal to the distal wrist, between the tendons of the flexor carpi radialis and the palmaris longus)to apply acupressure.

Group Type ACTIVE_COMPARATOR

P6 acupressure band

Intervention Type DEVICE

Comparison between groups 0-48 hours postoperatively.

Placebo group

In the end of the operation an identical Sea-Band® with no button and thereby no acupressure was placed unilaterally at the place of P6.

Group Type PLACEBO_COMPARATOR

Placebo band

Intervention Type OTHER

Comparison between groups 0-48 hours postoperatively

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

P6 acupressure band

Comparison between groups 0-48 hours postoperatively.

Intervention Type DEVICE

Placebo band

Comparison between groups 0-48 hours postoperatively

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sea-Band® Sea-Band® with no acupressure

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective infra-or supratentorial craniotomy
* Age ≥ 18 years

Exclusion Criteria

* Patients not able to actively participate in the study according to mental status or communicating problems and patients receiving an antiemetic less than twelve hours before surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Umeå University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ulrica G Nilsson

PhD, Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ulrica Nilsson, PhD

Role: STUDY_DIRECTOR

Umeå University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Department of Neurosurgery, Umeå University Hospital

Umeå, Västerbotten County, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-281-31M

Identifier Type: -

Identifier Source: org_study_id